CTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.87%

Insider Buying (Last 12 Months): C$51,436.60

Insider Selling (Last 12 Months): C$0.00

Crescita Therapeutics Insider Trading History Chart

Crescita Therapeutics Share Price & Price History

C^$0.44

▲ +0.02 (4.76%)

As of 12/4/2025 11:16 AM ET

Days: 30 | 90 | 365

Crescita Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/27/2024	Jose Darocha	Director	Buy	86,000	C$0.60	C$51,436.60
12/22/2023	Jose Darocha	Director	Buy	33,500	C$0.43	C$14,405.00

SEC Filings (Institutional Ownership Changes) for Crescita Therapeutics (TSE:CTX)

0.87% of Crescita Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Today's Range

Now: C$0.44

C$0.44

50 Day Range

MA: C$0.46

C$0.42

C$0.49

52 Week Range

Now: C$0.44

C$0.40

C$0.61

Volume

500 shs

Average Volume

19,722 shs

Market Capitalization

C$8.19 million

P/E Ratio

22.00

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Crescita Therapeutics?: Crescita Therapeutics' top insider shareholders include:
Jose Darocha (Director)
Learn More about top insider investors at Crescita Therapeutics.